Ken Rosenfield, MDMassachusetts General Hospital
Interventional Cardiology & Vascular Medicine
Chief Medical Officer, Penumbra, Inc.
Penumbra and RapidAI are working together to develop clinical and workflow solutions for pulmonary embolism to streamline triage and decision-making. Penumbra, Inc., is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions. RapidAI is the global leader in using AI to combat life-threatening vascular and neurovascular conditions. From home to hospital and ER to OR, RapidAI is leading the next evolution of clinical decision-making and patient workflow, bringing the end-to-end patient journey into focus.